Sara Mageit
The Moodbeam One wearable devices are being trialled at a GP practice first, with a potential UK national roll out in the pipeline.
The grant will support clinical research expansion in Europe and the development of Taliaz's mental health management platform.
The platform has shared three studies presented at the 2020 North American Cystic Fibrosis (CF) conference.
The acquisition aims to expand Medica's geographic reach, customer base and service offerings.
The launch coincides with 54gene being appointed as a country partner in a global registry study of healthcare workers exposed to COVID-19.
The nasal swab test device returns results in 12 minutes.
New study finds that as the pandemic accelerates regulatory acceptance, the market value is expected to grow by 865% over the next five years.
Fortunis Capital has awarded Clementine a place in its top 20 UK Impact Investment Fund.
The function that allows those to claim the support wasn't added to the app.
Roundup: GPDQ launches London's first private drive-through COVID-19 testing centre, PainChek annou…
Also, six councils improve employability and Covid support for learning disabilities.